AtriCure launches cryoanalgesia study

This study is designed to provide further clinical and scientific evidence,” CEO Michael Carrel said in a press release. The study plans to include patients undergoing unilateral thoracotomy cardiac procedures, and will evaluate pain scores and lung function recovery during hospital stays post-procedure, Atricure said. The primary objective of the study is to analyze whether intercostal cryoanalgesia with the CryoIce device along with standard of care paint management provides improved analgesic efficacy and a quicker, more complete recovery for patients undergoing unilateral thoracotomy cardiac procedures when compared to standard pain management. “Today’s pain management options offer relief while patients are hospitalized, but do little to address pain post-discharge. We have seen cryoanalgesia control pain and improve recovery post-operatively,” coordinating investigator Dr. Wei Lau of the Oakland University William Beaumont School of Medicine said in a prepared statement. Endpoints include ICU length of stay, total length of stay, opioid consumption and long-term neurologic recovery, AtriCure said. Centers participating in the study include the William Beaumont Hospital, the University of Michigan Medical center and the Cleveland Clinic Foundation. “I have continued to see the benefits of cryoanalgesia therapies in conjunction with minimally invasive mitral valve surgery. The benefit for patients is quite significant, and I look forward to deve...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Cardiovascular Clinical Trials Pain Management AtriCure Inc. Source Type: news